Finance Home - My Yahoo - Yahoo! - Help

Tuesday, December 15, 2009, 8:32PM ET - U.S. Markets Closed. Dow  0.47% Nasdaq  0.50%

Amarillo Biosciences Inc. (AMAR.OB)

At 3:22PM ET: 0.19   0.01 (2.70%)

MORE ON AMAR.OB

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Thu, Nov 19, 2009 • AMARILLO BIOSCIENCES INC Financials EDGAR Online Financials (Thu, Nov 19) Fri, Nov 13, 2009 • AMARILLO BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Fri, Nov 13) Wed, Nov 11, 2009 • Amarillo Biosciences Comments on New Findings of H1N1 in Animals and Potential Effect on Human Infections Marketwire (Wed, Nov 11) Fri, Oct 9, 2009 • Amarillo Biosciences Reports on Research Supporting Use of Interferon to Combat Influenza Marketwire (Fri, Oct 9) Wed, Oct 7, 2009 • Amarillo Biosciences Partners With Intas Pharmaceuticals to Treat Influenza in India Marketwire (Wed, Oct 7) Tue, Sep 29, 2009 • Amarillo Biosciences Appoints Bernard Cohen CFO PR Newswire (Tue, Sep 29) Tue, Sep 8, 2009 • Amarillo Biosciences' Phase 2 Australian Clinical Study of Interferon as a Preventative Agent Against H1N1 Flu Virus and Other Cold and Flu Viruses Reaches Midway Point Marketwire (Tue, Sep 8) Fri, Sep 4, 2009 • Berkshire Sells $21.6M Worth of Moodys TheStreet.com (Fri, Sep 4) Mon, Aug 17, 2009 • Dr. Manfred Beilharz, Co-Investigator in Australian Influenza Phase 2 Clinical Trial, Interviewed on 6PR Nightline Program Regarding Interferon and Influenza Marketwire (Mon, Aug 17) Wed, Aug 12, 2009 • AMARILLO BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Wed, Aug 12) Fri, Jul 10, 2009 • Amarillo Biosciences Reaches Enrollment Goal in Australian Influenza Phase 2 Clinical Trial Marketwire (Fri, Jul 10) Mon, Jun 29, 2009 • Amarillo Biosciences and CytoPharm Announce Start of Enrollment for Hepatitis C Study in Taiwan Marketwire (Mon, Jun 29) Fri, Jun 19, 2009 • Amarillo Biosciences Announces Completion of Screening Process for Influenza Study in Australia Marketwire (Fri, Jun 19) Fri, May 29, 2009 • Amarillo Biosciences Announces Influenza Study in Australia Well Underway With 60 Subjects Randomized to Date Marketwire (Fri, May 29) Wed, May 20, 2009 • Amarillo Biosciences Selects Accelovance for Its Next Influenza Study Marketwire (Wed, May 20) Fri, May 15, 2009 • AMARILLO BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report EDGAR Online (Fri, May 15) Mon, Apr 27, 2009 • Amarillo Biosciences Issues Letter to Shareholders Addressing Interferon and Swine Flu Outbreak Marketwire (Mon, Apr 27) Fri, Apr 24, 2009 • Amarillo Biosciences Supplies Oral Interferon for Taiwanese Hepatitis C Study Marketwire (Fri, Apr 24) Wed, Apr 15, 2009 • Amarillo Biosciences Supplies Oral Interferon for Australian Human Influenza Study Marketwire (Wed, Apr 15) Tue, Mar 31, 2009 • AMARILLO BIOSCIENCES INC Files SEC form 10-K, Annual Report EDGAR Online (Tue, Mar 31) Older Headlines - Download Recent Headlines View headlines from: Tue, Mar 31, 2009Tue, Mar 24, 2009Tue, Mar 17, 2009Tue, Mar 10, 2009Tue, Mar 3, 2009Tue, Feb 24, 2009Tue, Feb 17, 2009Tue, Feb 10, 2009Tue, Feb 3, 2009Tue, Jan 27, 2009 Add AMAR.OB News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage